Меню
Идёт набор NCT06124950

A Couple-based Gender-transformative Intervention on IPV Against Infertile Women

Без фазы С лечением Infertility, Female Violence, Domestic

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Gender-transformative intervention.
Кому может быть актуально
Состояния в реестре: Infertility, Female, Violence, Domestic. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Китай
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

A Couple-based Gender-transformative Intervention on Intimate Partner Violence Against Infertile Women

Обзор

This is a multicenter, open-label, randomized controlled trial conducted at two reproductive medicine centers in Beijing, China. Couples undergoing their first or second in-vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) cycle, diagnosed with female-factor infertility, and who have signed informed consent will be enrolled. Exclusion criteria include couples receiving donated oocytes, sperm, or embryos; those diagnosed with severe male-factor infertility or unexplained infertility; those undergoing preimplantation genetic testing (PGT); those who have not undergone embryo transfer within six months after oocyte retrieval; those with severe mental disorders; and those who withdraw from the study. Participants are will randomly allocated 1:1 by center to either the intervention or control group. Couples in the intervention group will receive five 60-minutes GTI sessions focusing on gender norms, gender equality, and healthy relationship skills, conducted by trained healthcare providers and social workers. The control group will receive standard reproductive care. A total of 376 infertile couples will be enrolled (188 couples per group). The primary outcome is the IPV rate against infertile women over the past 12 months.

Подробное описание

Infertility and intimate partner violence (IPV) are significant challenges in sexual and reproductive health, with a notable intersection as infertile women face higher IPV risks. However, the needs of infertile couples have been largely overlooked, and the effectiveness of gender-transformative interventions (GTIs) designed to challenge gender inequality and question gender norms in reducing IPV against infertile women has not been evaluated.

This is a multicenter, open-label, randomized controlled trial conducted at two reproductive medicine centers in Beijing, China (the Centers for Reproductive Medicine of Peking University Third Hospital and Beijing Obstetrics and Gynecology Hospital).

A multidisciplinary team of experts, including 8-10 experts in reproductive medicine, nursing, social work, psychiatry, family law, and evidence-based medicine, will be established to support the development of the intervention. Five 60-minutes GTI sessions will be delivered by trained nurses and social workers throughout participants' fertility treatment cycle. Intervention will be carried out at the 4 critical windows of opportunity for infertility treatment: (1) before entering the cycle; (2) during follicular monitoring; (3) the oocyte retrieval-embryo transfer phase; (4) 2 weeks after the embryo transfer (hCG pregnancy test), and (5) 28-30 days after the embryo transfer. The intervention components will equip couples with educational information on health and relationship and skills obtained from interactive activities designed with an explicit focus on challenging gender stereotypes, all of which could incite reflection on sociocultural norms and gender-related power inequality.

Participants are will randomly allocated 1:1 by center to either the intervention or control group. Couples in the intervention group will receive GTI sessions. The control group will receive standard reproductive care. A total of 376 infertile couples will be enrolled (188 couples per group).

Вмешательства

  • Поведенческое Gender-transformative intervention
    A multidisciplinary team of experts, including 8-10 experts in reproductive medicine, nursing, social work, psychiatry, family law, and evidence-based medicine, will be established to support the development of the intervention. Five 60-minutes intervention sessions will be delivered by trained nurses and social workers throughout participants' fertility treatment cycle. Intervention will be carried out at the 5 critical windows of opportunity for infertility treatment: (1) before entering the

Первичные конечные точки

  • Past-12-months Intimate Partner Violence against infertile women [Срок оценки: T0 (Baseline) and T0 + ~14 months (4 weeks after delivery)]
Вторичные конечные точки (12)
  • Past-12-months Intimate Partner Violence against male partners [Срок оценки: T0 (Baseline) and T0 + ~14 months (4 weeks after delivery)]
  • Past-3-months Intimate Partner Violence against infertile women [Срок оценки: T0 (Baseline); T0 + ~2months (28-30 days after embryo transfer); T0 + ~4 months (12-13 weeks of gestation); T0 + ~12-14 months (4 weeks after delivery)]
  • Past-3-months Intimate Partner Violence against male partners [Срок оценки: T0 (Baseline); T0 + ~2months (28-30 days after embryo transfer); T0 + ~4 months (12-13 weeks of gestation); T0 + ~12-14 months (4 weeks after delivery)]
  • Past-12-months Severe Intimate Partner Violence against infertile women [Срок оценки: T0 (Baseline) and T0 + ~14 months (4 weeks after delivery)]
  • Past-12-months severe Intimate Partner Violence against male partners [Срок оценки: T0 (Baseline) and T0 + ~14 months (4 weeks after delivery)]
  • Attitudes toward male gender roles [Срок оценки: T0 (Baseline); T0 + ~2months (28-30 days after embryo transfer); T0 + ~4 months (12-13 weeks of gestation); T0 + ~12-14 months (4 weeks after delivery)]
  • Martial quality and satisfaction [Срок оценки: T0 (Baseline); T0 + ~2months (28-30 days after embryo transfer); T0 + ~4 months (12-13 weeks of gestation); T0 + ~12-14 months (4 weeks after delivery)]
  • Couples' coping with stress [Срок оценки: T0 (Baseline); T0 + ~2months (28-30 days after embryo transfer); T0 + ~4 months (12-13 weeks of gestation); T0 + ~12-14 months (4 weeks after delivery)]
  • Patient satisfaction with infertility treatment [Срок оценки: T0 (Baseline); T0 + ~2months (28-30 days after embryo transfer); T0 + ~4 months (12-13 weeks of gestation); T0 + ~12-14 months (4 weeks after delivery)]
  • Human chorionic gonadotropin (hCG) Positive [Срок оценки: T0 + ~1.5 months]
  • Clinical pregnancy [Срок оценки: T0 + ~2 months (28-30 days after embryo transfer)]
  • Ongoing pregnancy [Срок оценки: T0 + ~4 months (12 weeks after embryo transfer)]

Критерии участия

Критерии включения

  • Couples who are undergoing their first or second IVF/ICSI cycle;
  • Couples diagnosed with female-factor infertility;
  • Couples who have signed consent.

Критерии исключения

  • Couples who receive donated oocytes, sperm, or embryos;
  • Couples diagnosed with severe male-factor infertility or unexplained infertility.
  • Couples who are undergoing Preimplantation Genetic Testing (PGT);
  • Couples who have not undergone embryo transfer within six months after oocyte retrieval;
  • Couples who have severe mental disorders;
  • Couples who withdrew from the study.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Скрининг

Центры проведения

Китай · 2 центра
  • Beijing Obstetrics and Gynecology Hospital — Пекин
  • Peking University Third Hospital — Пекин

Идентификаторы

NCT: NCT06124950 · M2023460

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗